AUS
NZ
UK
CA
USA
IND
Highlights
- Genus (GNS) stock has fluctuated between GBX 1,478 and GBX 2,378 over the past year.
- The company operates in the animal genetics industry across global markets, including North America and Europe.
- Insider trading activity revealed a recent sale of shares by a company insider
Genus plc (LON:GNS), a leading name in the animal genetics industry, has shown notable price fluctuations over the last year. The company's stock has ranged from a low of GBX 1,478 to a high of GBX 2,378, reflecting its market volatility. Genus, known for its operations in animal breeding and genetic services, boasts a market capitalization of £1.08 billion. Despite its relatively high P/E ratio of 13,700, the company has maintained a steady position within its industry, supported by its solid fundamentals such as a current ratio of 1.80 and a quick ratio of 1.08. Genus is also part of the broader landscape of LON healthcare stocks, which includes companies focused on health-related advancements and innovations.
As part of its business model, Genus operates through three main segments: Genus PIC, Genus ABS, and Genus Research and Development. The company specializes in selling breeding pigs and semen for the pork production industry, under its PIC brand, and has a significant presence in North America, Latin America, the UK, and several other global regions. The company’s ability to serve international markets further supports its position within the agricultural and animal genetics sectors.
In terms of insider activity, there was a recent transaction involving Jorgen Kokke, an insider at Genus, who sold 2,186 shares at an average price of GBX 1,956, resulting in a total value of £42,758. This move, while notable, accounts for only 0.75% of the total shares held by company insiders. It reflects the level of activity within the company and offers insights into its management’s view of the stock.
Despite the fluctuations, Genus continues to be a significant player in the global animal genetics market. Its steady market performance, bolstered by its solid financial ratios and international reach, demonstrates the company’s ongoing relevance within its sector.
